Tiedemann Michael 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-13 5:04 pm Purchase |
2023-01-03 | 13D | TransCode Therapeutics, Inc. RNAZ |
Tiedemann Michael | 417 9.700% |
417 (New Position) |
Filing |